ArticleiScience2026
Decoding cytarabine-induced damage in the prepubertal testis: A multi-omics atlas of ecosystem and inheritance.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric leukemia therapies can compromise future fertility, particularly in prepubertal boys who cannot bank sperm. We used dose-response histology, endocrine and sperm analyses, bulk and single-cell RNA-seq, and metabolomics to map cytarabine (Ara-C) injury in prepubertal mouse testes. Ara-C caused seminiferous-tubule disruption, hormone suppression, sperm loss, spermatogonial depletion linked to ferroptosis and replication arrest, stress remodeling of Sertoli and Leydig cells, and altered intercellular signaling centered on Sertoli hubs. Unexposed F1 offspring retained inflammatory, nucleotide, and energy-metabolism changes, suggesting intergenerational imprinting after paternal exposure. These findings define cell-type-specific vulnerabilities in the developing testis and nominate redox balance, ferroptosis, Sertoli stress pathways, Leydig inflammatory signaling, and niche communication as targets for fertility-preserving strategies during pediatric chemotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.